Concepedia

Kavita Natarajan

KN

Statistics

Publications

4

Citations

300

H-Index

4

Active since

2008

Affiliations

Augusta University(Current)

Novartis (United States)

Kavita Natarajan is an author at Augusta University specializing in medicine, molecular oncology, and oncology.

Publications per year

2008–2015

4

Publications

4

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells

Yongchao Wang, Warren Fiskus, Daniel G. Chong et al. · Blood · 2009 · 177 citations · Full text

Medicine, Oncology, Pharmacology +16

Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism

Jianguang Chen, Warren Fiskus, Kelly Eaton et al. · Blood · 2008 · 52 citations

Medicine, Oncology, Pharmacology +10

Clinical Experience With Three-Factor Prothrombin Complex Concentrate to Reverse Warfarin Anticoagulation in Intracranial Hemorrhage

Jeffrey A. Switzer, Jody Rocker, Phillip Mohorn et al. · Stroke · 2012 · 43 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Identification of human papillomavirus-16 E6 variation in cervical cancer and their impact on T and B cell epitopes

Anoop Kumar, Showket Hussain, Inderjit Singh Yadav et al. · Journal of Virological Methods · 2015 · 28 citations

Medicine, Immunology, Oncology +13

1–4 of 4